MIDLAND METROPOLITAN HOSPITAL PPP
The status, timeline and source of this project. A free account opens every field.
Source: European Investment Bank (EIB)
The new hospital of circa 80,000 m2 will enable the integration of acute hospital services, support the development of improved primary and community care and replace the current aging and unsuitable hospital facilities. The PPP is a rationalization of two existing outdated facilities and part of a comprehensive integrated healthcare plan for the served population.
- Status
- Closed
- Sector
- Hospital, Government
- Location
- United Kingdom
- Updated
- 22 Jul 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about MIDLAND METROPOLITAN HOSPITAL PPP
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | fully disbursed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | The new hospital of circa 80,000 m2 will enable the integration of acute hospital services, support the development of improved primary and community care and replace the current aging and unsuitable hospital facilities. The PPP is a rationalization of two existing outdated facilities and part of a comprehensive integrated healthcare plan for the served population. |
Original sector | Health |
Location
Country | United Kingdom (UK) |
Source
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Hospital, Government |
Article published date | 2026-01-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in United Kingdom
- RAF Fairford
- Upperton’s Pharmaceutical Development and GMP Manufacturing Facility, Nottingham, UK
- Michael Uren Biomedical Engineering Research Hub, London
- Sai Life Sciences’ Process Chemistry R&D Laboratory Expansion, Manchester
- Piramal’s ADC Manufacturing Facility Expansion, Grangemouth, Scotland
- Core Technology Facility, University Of Manchester, Manchester
- GSK’s New Biopharmaceutical Plant, Ulverston
- Penn Pharmaceutical Tredegar Plant
